MARLBOROUGH, Mass., Jan. 2, 2025
/PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will
participate in the 43rd Annual J.P. Morgan Healthcare
Conference on Monday, January 13,
2025, in San Francisco.
Mike Mahoney, chairman and chief
executive officer, will present at approximately 5:15 p.m. PT / 8:15 p.m.
ET. Mahoney will be joined by Dan
Brennan, executive vice president and chief financial
officer, and Kenneth Stein, M.D.,
senior vice president and chief medical officer, in a
question-and-answer session with the host analyst.
Additionally, the company will webcast its conference call
discussing financial results and business highlights for the fourth
quarter ended December 31, 2024, on
Wednesday, February 5, 2025, at
8:00 a.m. ET. The call will be hosted
by Mike Mahoney and Dan Brennan. The company will issue a news
release announcing financial results for the fourth quarter on
February 5 prior to the conference
call.
A live webcast and replay for each event will be accessible at
htts://investors.bostonscientific.com. The replays will be
available approximately one hour following the completion of each
event.
About Boston Scientific
Boston Scientific transforms lives through innovative medical
technologies that improve the health of patients around the world.
As a global medical technology leader for more than 45 years, we
advance science for life by providing a broad range of
high-performance solutions that address unmet patient needs and
reduce the cost of health care. Our portfolio of devices and
therapies helps physicians diagnose and treat complex
cardiovascular, respiratory, digestive, oncological, neurological
and urological diseases and conditions. Learn more at
www.bostonscientific.com and connect on LinkedIn
and X, formerly Twitter.
CONTACTS:
Chanel Hastings
Media Relations
+1 (508) 382-0288
Chanel.Hastings@bsci.com
Jon Monson
Investor Relations
+1 (508) 683-5450
BSXInvestorRelations@bsci.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/boston-scientific-announces-participation-in-the-jp-morgan-healthcare-conference-and-conference-call-discussing-fourth-quarter-2024-results-302340448.html
SOURCE Boston Scientific Corporation
